KPIs & Operating Metrics(New)
Balance Sheet
Cash Flow Statement
AcquisitionsAsset Writedowns and ImpairmentCapital ExpendituresCash from Financing ActivitiesCash from Investing ActivitiesCash from OperationsChange in Account PayablesChange in Accured ExpensesChange in Acquisitions & DivestmentsChange in CashChange in InventoryChange in ReceivablesChange in TaxesDeferred TaxesDepreciation & Amortization (CF)Depreciation and DepletionDivestmentsDividends Paid - CommonExchange Rate EffectFree Cash FlowGains from Investment SecuritiesNet Cash FlowNet IncomeOther Working Capital ChangesShare-based Compensation
Daily Values
Growth Metrics
Income Statement
Others
Ratios

Bristol Myers Squibb (BMY) Change in Account Payables (2016 - 2025)

Historic Change in Account Payables for Bristol Myers Squibb (BMY) over the last 17 years, with Q3 2025 value amounting to $160.0 million.

  • Bristol Myers Squibb's Change in Account Payables rose 14278.07% to $160.0 million in Q3 2025 from the same period last year, while for Sep 2025 it was $605.0 million, marking a year-over-year increase of 44504.5%. This contributed to the annual value of $184.0 million for FY2024, which is 707.07% down from last year.
  • Latest data reveals that Bristol Myers Squibb reported Change in Account Payables of $160.0 million as of Q3 2025, which was up 14278.07% from $13.0 million recorded in Q2 2025.
  • In the past 5 years, Bristol Myers Squibb's Change in Account Payables ranged from a high of $517.0 million in Q4 2024 and a low of -$374.0 million during Q3 2024
  • Over the past 5 years, Bristol Myers Squibb's median Change in Account Payables value was $13.0 million (recorded in 2025), while the average stood at $43.4 million.
  • The largest annual percentage gain for Bristol Myers Squibb's Change in Account Payables in the last 5 years was 71304.35% (2023), contrasted with its biggest fall of 76842.11% (2023).
  • Quarter analysis of 5 years shows Bristol Myers Squibb's Change in Account Payables stood at $226.0 million in 2021, then skyrocketed by 79.2% to $405.0 million in 2022, then rose by 9.63% to $444.0 million in 2023, then grew by 16.44% to $517.0 million in 2024, then tumbled by 69.05% to $160.0 million in 2025.
  • Its Change in Account Payables was $160.0 million in Q3 2025, compared to $13.0 million in Q2 2025 and -$85.0 million in Q1 2025.